Baltimore, MD, United States of America

Raymond J Patch

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1993-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Raymond J Patch

Introduction

Raymond J Patch is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target neurotransmitter receptors and protein kinase C activity. With a total of 2 patents, his work has implications for various therapeutic applications.

Latest Patents

One of his latest patents involves omega-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists. This invention pertains to antagonists of excitatory amino acid neurotransmitter receptors, detailing their method of preparation and compositions containing them. The general formula includes various groups that can be selected based on specific chemical properties. Another significant patent focuses on protein kinase C modulators, which includes compounds that inhibit PKC activity in mammals. This patent also discusses pharmaceutical compositions that utilize these compounds and methods for their application.

Career Highlights

Throughout his career, Raymond J Patch has worked with prominent companies in the pharmaceutical industry, including Nova Pharmaceutical Corporation and Guilford Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to the advancement of medical science through innovative research and development.

Collaborations

Raymond has collaborated with notable colleagues such as Ronald M Burch and Barry G Shearer. These partnerships have likely enhanced the scope and impact of his research endeavors.

Conclusion

Raymond J Patch's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…